{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:15:15Z","timestamp":1770894915116,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["neurotox res"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/bf03033506","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T17:39:30Z","timestamp":1248111570000},"page":"231-240","source":"Crossref","is-referenced-by-count":29,"title":["Histamine H3 receptor ligands modulate L-dopa-evoked behavioral responses and L-dopa-derived extracellular dopamine in dopamine-denervated rat striatum"],"prefix":"10.1007","volume":"13","author":[{"given":"Przemyslaw","family":"Nowak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Bortel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Dabrowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izabela","family":"Biedka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"Slomian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Roczniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard M.","family":"Kostrzewa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryszard","family":"Brus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03033506_CR1","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1006\/nbdi.2001.0413","volume":"8","author":"OV Anichtchik","year":"2001","unstructured":"Anichtchik OV, N Peitsaro, JO Rinne, H Kalimo and P Panula (2001) Distribution and modulation of histamine H3 receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson\u2019s disease.Neurobiol. Dis. 8, 707\u2013716.","journal-title":"Neurobiol. Dis."},{"key":"BF03033506_CR2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.bjp.0704053","volume":"133","author":"JA Arias-Monatano","year":"2001","unstructured":"Arias-Monatano JA, B Floran, M Garcia, J Aceves and JM Young (2001) Histamine H3 receptor-mediated inhibition of depolarization-induced, dopamine D1 receptor-dependent release of [3H]-\u03b3-aminobutryic acid from rat striatal slices.Br. J. Pharmacol. 133, 165\u2013171.","journal-title":"Br. J. Pharmacol."},{"key":"BF03033506_CR3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1471-4159.1988.tb04841.x","volume":"51","author":"JM Arrang","year":"1988","unstructured":"Arrang JM, B Devaux, JP Chodkiewicz and JC Schwartz (1988) H3-receptors control histamine release in human brain.J. Neurochem. 51, 105\u2013108.","journal-title":"J. Neurochem."},{"key":"BF03033506_CR4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0301-0082(00)00039-3","volume":"63","author":"RE Brown","year":"2001","unstructured":"Brown RE, DR Stevens and HL Haas (2001) The physiology of brain histamine.Prog. Neurobiol. 63, 637\u2013672.","journal-title":"Prog. Neurobiol."},{"key":"BF03033506_CR5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/10604450213042","volume":"12","author":"R Brus","year":"2002","unstructured":"Brus R, P Nowak, A Sokola, RM Kotrzewa and J Shani (2002) Behavioral and biochemical effects of new central dopamine D3 and D4 receptor antagonists in rats.Pharmacol. Rev. Comm. 12, 39\u201359.","journal-title":"Pharmacol. Rev. Comm."},{"key":"BF03033506_CR6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF03033153","volume":"5","author":"R Brus","year":"2003","unstructured":"Brus R, RM Kostrzewa, P Nowak, KW Perry and JP Kostrzewa (2003) Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine- lesioned rats.Neurotox. Res. 5, 329\u2013338.","journal-title":"Neurotox. Res."},{"key":"BF03033506_CR7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(94)90498-7","volume":"259","author":"J Clapham","year":"1994","unstructured":"Clapham J and GJ Kilpatrick (1994) Thioperamide, the selective histamine H3 receptor antagonist, attenuates stimulantinduced locomotor activity in the mouse.Eur. J. Pharmacol. 259, 107\u2013114.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03033506_CR8","unstructured":"Creese I and SD Iversen (1975) Behavioral sequel of dopaminergic degeneration: post-synaptic supersensitivity, In: Modern Pharmacology - Toxicology (Ellsodin JR and JR Buney, Eds.) (Marcel Dekker Publ.) 3, 171\u2013190."},{"key":"BF03033506_CR9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/syn.890080208","volume":"8","author":"P Cumming","year":"1991","unstructured":"Cumming P, C Shaw and SR Vincent (1991) High affinity histamine binding site is the H3 receptor: characterization and autoradiographic localization in rat brain.Synapse 8, 144\u2013151.","journal-title":"Synapse"},{"key":"BF03033506_CR10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0014-2999(00)00608-7","volume":"404","author":"D Farzin","year":"2000","unstructured":"Farzin D and M Attarzadeh (2000) Influence of different histamine receptor agonists and antagonists on apomorphineinduced licking behavior in rat.Eur. J. Pharmacol. 404, 169\u2013174.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03033506_CR11","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1021\/jm00017a018","volume":"38","author":"CR Ganellin","year":"1995","unstructured":"Ganellin CR, SK Hosseini, YS Khalaf, W Tertiuk, JM Arrang, M Garbarg, X Ligneau and JC Schwartz (1995) Design of potent non-thiourea H3-receptor histamine antagonists.J. Med. Chem. 38, 3342\u20133350.","journal-title":"J. Med. Chem."},{"key":"BF03033506_CR12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0022-3565(25)10340-6","volume":"263","author":"M Garbarg","year":"1992","unstructured":"Garbarg M, JM Arrang, A Rouleau, X Ligneau, MD Tuong, JC Schwartz and CR Ganellin (1992) S-[2-(4-imidazolyl) ethyl] isothiourea, a highly specific and potent histamine H3 receptor agonist.J. Pharmacol. Exp. Ther. 263, 304\u2013310.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF03033506_CR13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0306-4522(97)00100-0","volume":"80","author":"M Garcia","year":"1997","unstructured":"Garcia M, B Floran, JA rias-Monatano, JM Young and Aceves (1997) Histamine H3 receptor activation selectively inhibits dopamine D1 receptor-dependent [3H]GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulata.Neuroscience 80, 241\u2013249.","journal-title":"Neuroscience"},{"key":"BF03033506_CR14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbr.2004.03.007","volume":"154","author":"M Garcia-Ramirez","year":"2004","unstructured":"Garcia-Ramirez M, J Aceves and JA Arias-Montano (2004) Intranigral injection of the H3 agonist immepip and systemic apomorphine elicit ipsilateral turning behaviour in naive rats, but reduce contralateral turning in hemiparkinsonian rats.Behav. Brain Res. 154, 409\u2013415.","journal-title":"Behav. Brain Res."},{"key":"BF03033506_CR15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000113472","volume":"38","author":"WR Gibb","year":"1997","unstructured":"Gibb WR (1997) Functional neuropathology in Parkinson\u2019s disease.Eur. Neurol. 38, 21\u201325.","journal-title":"Eur. Neurol."},{"key":"BF03033506_CR16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1353-8020(00)00007-9","volume":"6","author":"M Huotari","year":"2000","unstructured":"Huotari M, K Kukkonen, N Liikka, T Potasev, A Raasmaja and PT Mannisto (2000) Effects of histamine H3-ligands on the levodopa-induced turning behavior of hemiparkinsonian rats.Parkinsonism Relat. Disord. 6, 159\u2013164.","journal-title":"Parkinsonism Relat. Disord."},{"key":"BF03033506_CR17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.expneurol.2004.10.002","volume":"191","author":"TH Johnston","year":"2005","unstructured":"Johnston TH, J Lee, J Gomez-Ramirez, SH Fox and JM Brotchie (2005) A simple rodent assay for thein vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson\u2019s disease.Exp. Neurol. 191, 243\u2013250.","journal-title":"Exp. Neurol."},{"key":"BF03033506_CR18","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1046\/j.1471-4159.2001.00184.x","volume":"76","author":"K Kannari","year":"2001","unstructured":"Kannari K, H Yamato, H Shen, M Tomiyama, T Suda and M Matsunaga (2001) Activation of 5-HT1A but not 5-HT1B receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation.J. Neurochem. 76, 1346\u20131353.","journal-title":"J. Neurochem."},{"key":"BF03033506_CR19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0091-3057(91)90146-S","volume":"39","author":"RM Kostrzewa","year":"1991","unstructured":"Kostrzewa RM and L Gong (1991) Supersensitized D1 receptors mediate enhanced oral activity after neonatal 6-OHDA.Pharmacol. Biochem. Behav. 39, 677\u2013682.","journal-title":"Pharmacol. Biochem. Behav."},{"key":"BF03033506_CR20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF03033281","volume":"6","author":"RM Kostrzewa","year":"2004","unstructured":"Kostrzewa RM, JP Kostrzewa, P Nowak, RA Kostrzewa and R Brus (2004) Dopamine D2 agonist priming in intact and dopamine-lesioned rats.Neurotox. Res. 6, 457\u2013462.","journal-title":"Neurotox. Res."},{"key":"BF03033506_CR21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00726-005-0162-4","volume":"28","author":"RM Kostrzewa","year":"2005","unstructured":"Kostrzewa RM, P Nowak, JP Kostrzewa, RA Kostrzewa and R Brus (2005) Peculiarities of L-DOPA treatment of Parkinson\u2019s disease.Amino Acids 28, 157\u2013164.","journal-title":"Amino Acids"},{"key":"BF03033506_CR22","first-page":"277","volume":"70","author":"RM Kostrzewa","year":"2006","unstructured":"Kostrzewa RM, JP Kostrzewa, R Brus, RA Kostrzewa and P Nowak (2006) Proposed animal model of severe Parkinson\u2019s disease: neonatal 6-hydroxydopamine lesion of dopaminergic innervation of striatum.J. Neural. Transm. (Suppl.)70, 277\u2013279.","journal-title":"J. Neural. Transm."},{"key":"BF03033506_CR23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF03033481","volume":"11","author":"RM Kostrzewa","year":"2007","unstructured":"Kostrzewa RM, NY Huang, JP Kostrzewa, P Nowak and R Brus (2007) Modeling tardive dyskinesia: predicitive 5-HT2C receptor antagonist treatment.Neurotox. Res. 11, 41\u201350.","journal-title":"Neurotox. Res."},{"key":"BF03033506_CR24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0006-8993(98)01248-7","volume":"817","author":"T Maeda","year":"1999","unstructured":"Maeda T, K Kannari, T Suda and M Matsunaga (1999) Loss of regulation by presynaptic dopamine D2 receptors of exogenous L-DOPA-derived dopamine release in the dopaminergic denervated striatum.Brain Res. 817, 185\u2013191.","journal-title":"Brain Res."},{"key":"BF03033506_CR25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0378-4347(00)84308-X","volume":"221","author":"O Magnusson","year":"1980","unstructured":"Magnusson O, LB Nilsson and D Westerlund (1980) Simultaneous determination of dopamine, DOPAC and homovanillic acid. Direct injection of supernatants from brain tissue homogenates in a liquid chromatography--electrochemical detection system.J. Chromatogr. 221, 237\u2013247.","journal-title":"J. Chromatogr."},{"key":"BF03033506_CR26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0006-8993(90)91240-H","volume":"526","author":"MI Martinez-Mir","year":"1990","unstructured":"Martinez-Mir MI, H Pollard, J Moreau, JM Arrang, M Ruat, E Traiffort, JC Schwartz and JM Palacios (1990) Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates.Brain Res. 526, 322\u2013327.","journal-title":"Brain Res."},{"key":"BF03033506_CR27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","volume":"28","author":"DJ Moore","year":"2005","unstructured":"Moore DJ, AB West, VL Dawson and TM Dawson (2005) Molecular pathophysiology of Parkinson\u2019s disease.Annu. Rev. Neurosci. 28, 57\u201387.","journal-title":"Annu. Rev. Neurosci."},{"key":"BF03033506_CR28","first-page":"251","volume":"53","author":"P Nowak","year":"2002","unstructured":"Nowak P, R Brus, J Oswiecimska, A Sokola and RM Kostrzewa (2002) 7-Nitroindazole enhances amphetamine-evoked dopamine release in rat striatum. Anin vivo microdialysis and voltammetric study.J. Physiol. Pharmacol. 53, 251\u2013263.","journal-title":"J. Physiol. Pharmacol."},{"key":"BF03033506_CR29","first-page":"325","volume":"56","author":"P Nowak","year":"2005","unstructured":"Nowak P, RM Kostrzewa, A Kwiecinski, A Bortel, L Labus and R Brus (2005) Neurotoxic action of 6-hydroxydopamine on the nigrostriatal dopaminergic pathway in rats sensitized with D-amphetamine.J. Physiol. Pharmacol. 56, 325\u2013333.","journal-title":"J. Physiol. Pharmacol."},{"key":"BF03033506_CR30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejphar.2006.08.092","volume":"552","author":"P Nowak","year":"2006","unstructured":"Nowak P, J Dabrowska, G Szczerbak, I Biedka, R Brus and RM Kostrzewa (2006a) Effect of the central H3 histamine receptor agonist and antagonist on D1 evoked behavioral responses in rats with dopaminergic system denervation.Eur. J. Pharmacol. 552, 46\u201354.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03033506_CR31","first-page":"583","volume":"57","author":"P Nowak","year":"2006","unstructured":"Nowak P, G Szczerbak, I Biedka, M Drosik, RM Kostrzewa and R Brus (2006b) Effect of ketanserin and amphetamine on nigrostriatal neurotransmission and reactive oxygen species in Parkinsonian rats.In vivo microdialysis study.J. Physiol. Pharmacol. 57, 583\u2013597.","journal-title":"J. Physiol. Pharmacol."},{"key":"BF03033506_CR32","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1460-9568.2005.04301.x","volume":"22","author":"K Ossowska","year":"2005","unstructured":"Ossowska K, J Wardas, M Smialowska, K Kuter, T Lenda, JM Wieronska, B Zieba, P Nowak, J Dabrowska, A Bortel, A Kwiecinski and S Wolfarth (2005) A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson\u2019s disease?Eur. J. Neurosci. 22, 1294\u20131304.","journal-title":"Eur. J. Neurosci."},{"key":"BF03033506_CR33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s002130050882","volume":"142","author":"C Perez-Garcia","year":"1999","unstructured":"Perez-Garcia C, L Morales, MV Cano, I Sancho and LF Alguacil (1999) Effects of histamine H3 receptor ligands in experimental models of anxiety and depression.Psychopharmacology (Berl.) 142, 215\u2013220.","journal-title":"Psychopharmacology (Berl.)"},{"key":"BF03033506_CR34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0306-4522(93)90191-H","volume":"52","author":"H Pollard","year":"1993","unstructured":"Pollard H, J Moreau, JM Arrang and JC Schwartz (1993) A detailed autoradiographic mapping of histamine H3 receptors in rat brain areas.Neuroscience 52, 169\u2013189.","journal-title":"Neuroscience"},{"key":"BF03033506_CR35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0304-3940(94)90279-8","volume":"178","author":"JH Ryu","year":"1994","unstructured":"Ryu JH, K Yanai and T Watanabe (1994) Marked increase in histamine H3 receptors in the striatum and substantia nigra after 6-hydroxydopamine-induced denervation of dopaminergic neurons: an autoradiographic study.Neurosci. Lett. 178, 19\u201322.","journal-title":"Neurosci. Lett."},{"issue":"3","key":"BF03033506_CR36","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1476-5381.1996.tb15441.x","volume":"118","author":"JH Ryu","year":"1996","unstructured":"Ryu JH, K Yanai, XL Zhao and T Watanabe (1996) The effect of dopamine D1 receptor stimulation on the up-regulation of histamine H3-receptors following destruction of the ascending dopaminergic neurones.Br. J. Pharmacol. 118(3), 585\u2013592.","journal-title":"Br. J. Pharmacol."},{"key":"BF03033506_CR37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neulet.2004.04.045","volume":"364","author":"E Sanchez-Lemus","year":"2004","unstructured":"Sanchez-Lemus E and JA Arias-Montano (2004) Histamine H3 receptor activation inhibits dopamine D1 receptor-induced cAMP accumulation in rat striatal slices.Neurosci. Lett. 364, 179\u2013184.","journal-title":"Neurosci. Lett."},{"key":"BF03033506_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01244933","volume":"93","author":"E Schlicker","year":"1993","unstructured":"Schlicker E, K Fink, M Detzner and M Gothert (1993) Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors.J. Neural. Transm. Gen. Sect. 93, 1\u201310.","journal-title":"J. Neural. Transm. Gen. Sect."},{"key":"BF03033506_CR39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuroscience.2006.01.045","volume":"140","author":"YN Song","year":"2006","unstructured":"Song YN, HZ Li, JN Zhu, CL Guo and JJ Wang (2006) Histamine improves rat rota-rod and balance beam performances through H2 receptors in the cerebellar interpositus nucleus.Neuroscience 140, 33\u201343.","journal-title":"Neuroscience"},{"key":"BF03033506_CR40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9673(01)89321-3","volume":"515","author":"H Takeda","year":"1990","unstructured":"Takeda H, T Matsumiya and T Shibuya (1990) Detection and identification modes for the highly sensitive and simultaneous determination of various biogenic amines by coulometric high-performance liquid chromatography.J. Chromatogr. 515, 265\u2013278.","journal-title":"J. Chromatogr."},{"key":"BF03033506_CR41","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00001756-199902250-00034","volume":"10","author":"H Tanaka","year":"1999","unstructured":"Tanaka H, K Kannari, T Maeda, M Tomiyama, T Suda and M Matsunaga (1999) Role of serotonergic neurons in L-DOPAderived extracellular dopamine in the striatum of 6-OHDAlesioned rats.Neuroreport 10, 631\u2013634.","journal-title":"Neuroreport"},{"key":"BF03033506_CR42","doi-asserted-by":"crossref","first-page":"8704","DOI":"10.1523\/JNEUROSCI.2690-04.2004","volume":"24","author":"S Threlfell","year":"2004","unstructured":"Threlfell S, SJ Cragg, I Kallo, GF Turi, CW Coen and SA Greenfield (2004) Histamine H3 receptors inhibit serotonin release in substantia nigra pars reticulata.J. Neurosci. 24, 8704\u20138710.","journal-title":"J. Neurosci."},{"key":"BF03033506_CR43","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/mol.62.2.389","volume":"62","author":"H Toyota","year":"2002","unstructured":"Toyota H, C Dugovic, M Koehl, AD Laposky, C Weber, K Ngo, Y Wu, DH Lee, K Yanai, E Sakurai, T Watanabe, C Liu, J Chen, AJ Barbier, FW Turek, WP Fung-Leung and TW Lovenberg (2002) Behavioral characterization of mice lacking histamine H3 receptors.Mol. Pharmacol. 62, 389\u2013397.","journal-title":"Mol. Pharmacol."},{"key":"BF03033506_CR44","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1002\/mds.20459","volume":"20","author":"K Widnell","year":"2005","unstructured":"Widnell K (2005) Pathophysiology of motor fluctuations in Parkinson\u2019s disease.Mov. Disord. 20, S17-S22.","journal-title":"Mov. Disord."},{"key":"BF03033506_CR45","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0022-3565(24)29209-0","volume":"299","author":"K Wieland","year":"2001","unstructured":"Wieland K, G Bongers, Y Yamamoto, T Hashimoto, A Yamatodani, WM Menge, H Timmerman, TW Lovenberg and R Leurs (2001) Constitutive activity of histamine H3 receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H3 antagonists.J. Pharmacol. Exp. Ther. 299, 908\u2013914.","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033506.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03033506\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033506","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T05:30:34Z","timestamp":1739251834000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03033506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":45,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["BF03033506"],"URL":"https:\/\/doi.org\/10.1007\/bf03033506","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}